진료일정
진료 클리닉
시간 | 월(14) | 화(15) | 수(16) | 목(17) | 금(18) | 토(19) |
---|---|---|---|---|---|---|
오전 | 오전진료 | 오전진료 | ||||
오후 | 오후진료 |
토요진료는 진료 예약 > 토요 진료시간표를 확인해주시기 바랍니다.
류헌모 혈액·종양내과
Cancer research and treatment
Randomized Phase III Trial of Irinotecan Plus Cisplatin Versus Etoposide Plus Cisplatin in Chemotherapy-Naive Korean Patients with Extensive-Disease Small Cell Lung Cancer.
Korean J Intern Med
Comparison of three risk stratification models for non-clear cell renal cell carcinoma patients treated with temsirolimus as first-line therapy.
Cancer research and treatment
Randomized Phase III Trial of Irinotecan Plus Cisplatin versus Etoposide Plus Cisplatin in Chemotherapy-Naive Korean Patients with Extensive-Disease Small Cell Lung Cancer
Cancer research and treatment
Prospective Validation of The Korean Cancer Study Group Geriatric Score (KG)-7, a Novel Geriatric Screening Tool, in Older Patients with Advanced Cancer Undergoing First-line Palliative Chemotherapy
Korean Association of Internal Medicine
Comparison of three risk stratification models for non-clear cell renal cell carcinoma patients treated with temsirolimus as first-line therapy
AlphaMed Press
Polypharmacy, Inappropriate Medication Use, and Drug Interactions in Older Korean Patients with Cancer Receiving First-Line Palliative Chemotherapy
Springer International
Interference with daily functioning by breakthrough pain in patients with cancer